Day: June 7, 2021

Las Vegas, NV, June 07, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Hemp, Inc. (OTC PINK: HEMP) announces today that after the long-standing 5 year-old SEC civil case, the final filing has been completed and the Company is moving forward.  Hemp, Inc. and Bruce Perlowin agreed to settle the civil suit against them without admitting or denying the SEC’s allegations.  Perlowin has transitioned from CEO to Chief Visionary Consultant (CVC) and while he no longer manages the day-to-day tasks of the company, he remains the true visionary Hemp, Inc. shareholders have come to admire and respect. The Company remains committed to its longstanding goals and is aggressively moving forward and continues to add new blood and new ideas to the management of the company. Hemp, Inc. has expanded its knowledge base by bringing in a new CEO and...

Although Icelandair Group’s traffic data continue to reflect the impact of the COVID-19 pandemic, the total capacity and the number of passengers increased considerably compared to May 2020 as well as between months, from April 2021. The total number of Icelandair’s passengers on international and domestic flights was around 40,000. Thereof, the total number of passengers on international flights was around 21,900 compared to around 3,200 in May 2020. The number of passengers to Iceland was around 14,400 in May 2021 and from Iceland around 5,700. The load factor on international flights was 35.2% compared to 29.4% in May 2020. It should be noted that in recent months, Icelandair has used Boeing 767 aircraft on several routes instead of smaller aircraft to increase cargo capacity, which in turn negatively impacts the load factor. The capacity...

PLANO, Texas, June 07, 2021 (GLOBE NEWSWIRE) — Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” or “we”), a clinical-stage biopharmaceutical company, today announced that management will participate in a virtual Fireside chat and hold 1×1 meetings at the Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8, 2021. About Reata Pharmaceuticals, Inc. Reata is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways involved in the regulation of cellular metabolism and inflammation. Reata’s two most advanced clinical candidates, bardoxolone methyl (“bardoxolone”) and omaveloxolone, target the important transcription factor Nrf2 that promotes the resolution of inflammation by restoring...

TORONTO, June 07, 2021 (GLOBE NEWSWIRE) — (TSX:BREA) Brompton Funds Limited (the “Manager”), is pleased to announce that Brompton Global Real Assets Dividend ETF (“BREA”) will change its name to Brompton Sustainable Real Assets Dividend ETF, and the investment strategy will be amended to explicitly include ESG considerations, effective on or about Wednesday June 16, 2021. BREA’s investment strategy will also be updated to include the following: “The Manager will integrate environmental, social and corporate governance (“ESG”) considerations to complement its security selection process. The qualitative ESG policies and practices considered by the Manager may include, but are not limited to, a company’s environmental sustainability, diversity of employees and corporate governance.” BREA invests in a diversified actively managed portfolio...

Today, June 7th Reykjavik Energy (OR, Orkuveita Reykjavíkur) concluded a green bond offering, increasing the size of the green bond series, OR1802142 GB. OR issued bonds amounting to 2.000 m.kr. in nominal terms at a yield of 4,60%. The size of the bond series is now 4.198 m.kr. in nominal terms. Fossar Markets managed the process on behalf of OR as well as enlisting the green bond series on the Nasdaq Iceland Sustainable Bond market. For further information please contact:Ingvar Stefánsson, CFO, tel: +354 516 6100, email: ingvar.stefansson@or.is Matei Manolescu, Capital Markets, Fossar Markets, tel: +354 522 4008, email: matei.manolescu@fossarmarkets.com 

Programs now available to support patients and families with their treatment journey Collaborations with Veterans Health Administration, CVS Health and NAFC focused on health disparities in underserved communities Value-based agreements in progress with Cigna and other payers CAMBRIDGE, Mass. and WOODCLIFF LAKE, N.J., June 07, 2021 (GLOBE NEWSWIRE) — Following today’s U.S. Food and Drug Administration’s (FDA) accelerated approval of ADUHELMTM (aducanumab-avwa) as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease by reducing amyloid beta plaques in the brain, Biogen (Nasdaq: BIIB) and Eisai Inc., U.S. subsidiary of Eisai Co., Ltd., announced a range of programs intended to support access for all qualified patients, including traditionally underserved populations. These initiatives...

Los Angeles, CA, June 07, 2021 (GLOBE NEWSWIRE) —  (GLOBE NEWSWIRE) — KRONOS ADVANCED TECHNOLOGIES, INC. (OTC MARKETS: KNOS) (“KNOS” or the “Company”), an innovation-driven product development and production company that has significantly changed the way air is moved, filtered, and sterilized announced today that the Company’s best selling patented air purifiers product line is now available for purchase online through Wayfair.com, one of the world’s largest online destinations for home furnishings and décor. “We’re very excited to have our products available through Wayfair.com,” said Michael Rubinov, President of Kronos. “Wayfair is one of the largest online-only home goods retailers in the world, with almost 17,000 employees and more than 33 million active customers....

The accumulation of amyloid beta plaques in the brain is a defining pathology of Alzheimer’s disease In clinical trials, ADUHELM reduced amyloid beta plaques by 59 to 71 percent at 18 months of treatment CAMBRIDGE, Mass. and TOKYO, June 07, 2021 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) and Eisai, Co., Ltd. (Tokyo, Japan) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for ADUHELM™ (aducanumab-avwa) as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease by reducing amyloid beta plaques in the brain. The accelerated approval has been granted based on data from clinical trials demonstrating the effect of ADUHELM on reducing amyloid beta plaques, a biomarker that is reasonably likely to predict clinical benefit, in this case a reduction in...

ATLANTA, June 07, 2021 (GLOBE NEWSWIRE) — Labor SMART, Inc. (LTNC) (the “Company”), announced that it entered into an endorsement deal with Jacksonville Jaguars tight end Chris Manhertz. Manhertz will endorse and use Takeover’s NXT LVL Hydrogen Infused Spring Water during both his off-season and in-season training and competition. Manhertz finished the 2020 season with six catches on eight targets for 52 yards in 16 games played. Manhertz has 12 receptions on 1,531 offensive snaps in 70 NFL appearances.  Joe Pavlik Labor Smart Inc., CEO & Takeover Industries President and Chief Science Officer commented, “We’re excited to have Chris as part of team as he’s been a leader both on and off the field. His efforts within the community and commitment to give back fits in synch perfectly with our company philosophy. It will be interesting...

Octopus Titan VCT plc 7 June 2021 Directorate Changes Resignation of Mark Hawkesworth Octopus Titan VCT plc (“the Company”) announces the resignation of Mark Hawkesworth as a Director of the Company with effect from the close of the 2021 Annual General Meeting which took place today. John Hustler, Chairman of the Company, said “Mark has been with Octopus Titan since 2008 and over the years I have particularly valued his experience and advice. On behalf of the Board and shareholders, I would like to thank him for his many years working with us and wish him well in his retirement.” Following Mr Hawkesworth’s resignation, Tom Leader has been appointed to act as Chairman of the Audit Committee. Appointment of Gaenor Bagley Following a 30-year career in professional services, where she held a variety of leadership positions including at Board...